GlobeNewsWire
23 Oct 2025, 00:40 UTC · 52w ago
Verdict
Headline takes no side. We score JSPR −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Jasper Therapeutics allegedly lacked controls to ensure third-party manufacturers complied with cGMP regulations, confounding clinical study results and negatively impacting regulatory and commercial prospects for briquilimab.
More negative than 99% of claims this week
When the manufacturing issues were revealed on July 7, 2025, Jasper's stock price fell 55.1% to close at $3.04 per share.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 99% of claims this week
The cGMP failures increased the likelihood of disruptive cost-reduction measures for Jasper Therapeutics.
More negative than 94% of claims this week
A class action lawsuit was filed against Jasper Therapeutics alleging the company overstated its business, financial, and briquilimab clinical prospects.
More negative than 85% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit alleging it misled investors, resulting in a 55.1% stock price drop.
More negative than 86% of ticker scores this week
The company is being investigated for allegations that it misled investors regarding drug viability and efficacy.
More negative than 86% of ticker scores this week
The company is being investigated for allegations that it misled investors in connection with its IPO.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
36m ago
−79.0%
Price agrees with the score
$0.5043 vs $2.40 close before publication (Oct 22) · not market-adjusted
JSPR chart →
